Jeffrey Myers shares his career experiences and advice in an interview with professional colleague Ivan Damjanov

Can you determine the hereditary syndrome that this renal tumor is indicative of?

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

Do changes in family and life circumstances affect how you view your patients? And if so, is that necessarily a bad thing?

In a quiet, yet purposeful way, the world of pathology changed with little fanfare on February 22, 2019

The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years

A pioneer of epigenetics discusses his career and what he has learned from a fascinating journey through medicine

How consolidating molecular diagnostics has improved service delivery for the Great Ormond Street Hospital microbiology department

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care